Morgan IM - Search Results

1

Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.

Morgan IM, Asano M, Håvarstein LS, Ishikawa H, Hiiragi T, Ito Y, Vogt PK. Morgan IM, et al. Oncogene. 1993 May;8(5):1135-40. Oncogene. 1993. PMID: 8479738

2

Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation.

Håvarstein LS, Morgan IM, Wong WY, Vogt PK. Håvarstein LS, et al. Among authors: morgan im. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):618-22. doi: 10.1073/pnas.89.2.618. Proc Natl Acad Sci U S A. 1992. PMID: 1309952 Free PMC article.

3

c-Jun causes focus formation and anchorage-independent growth in culture but is non-tumorigenic.

Wong WY, Håvarstein LS, Morgan IM, Vogt PK. Wong WY, et al. Among authors: morgan im. Oncogene. 1992 Oct;7(10):2077-80. Oncogene. 1992. PMID: 1408150

4

Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.

Morgan IM, Ransone LJ, Bos TJ, Verma IM, Vogt PK. Morgan IM, et al. Oncogene. 1992 Jun;7(6):1119-25. Oncogene. 1992. PMID: 1594243

5

The oncogenicity of Jun.

Vogt PK, Morgan IM, Håvarstein L, Su H, Hartl M, Schuur E. Vogt PK, et al. Among authors: morgan im. Leukemia. 1992;6 Suppl 3:184S-186S. Leukemia. 1992. PMID: 1602820

6

The genetics of jun.

Vogt PK, Morgan I. Vogt PK, et al. Semin Cancer Biol. 1990 Feb;1(1):27-36. Semin Cancer Biol. 1990. PMID: 2133108 Review.

7

Efficient induction of fibrosarcomas by v-jun requires mutations in the DNA binding region and the transactivation domain.

Morgan IM, Håvarstein LS, Wong WY, Luu P, Vogt PK. Morgan IM, et al. Oncogene. 1994 Oct;9(10):2793-7. Oncogene. 1994. PMID: 8084584

8

Differential and antagonistic effects of v-Jun and c-Jun.

Gao M, Morgan I, Vogt PK. Gao M, et al. Cancer Res. 1996 Sep 15;56(18):4229-35. Cancer Res. 1996. PMID: 8797597

9

UVB irradiation reduces the half-life and transactivation potential of the human papillomavirus 16 E2 protein.

Taylor ER, Boner W, Dornan ES, Corr EM, Morgan IM. Taylor ER, et al. Among authors: morgan im. Oncogene. 2003 Jul 17;22(29):4469-77. doi: 10.1038/sj.onc.1206746. Oncogene. 2003. PMID: 12881703

10

Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2.

Okoye A, Cordano P, Taylor ER, Morgan IM, Everett R, Campo MS. Okoye A, et al. Among authors: morgan im. Virus Res. 2005 Mar;108(1-2):1-14. doi: 10.1016/j.virusres.2004.07.004. Virus Res. 2005. PMID: 15681049 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters